Prostate Care

What Prostate Care does

Prostate Care Limited is a UK-based managed services provider specializing in precision prostate cancer diagnostics and treatment. Founded in 2004 and headquartered at Milton Park Innovation Centre in Abingdon, the company delivers MR/US fusion biopsy, multiparametric MRI (mpMRI) contouring and biopsy planning, and High Intensity Focused Ultrasound (HIFU) focal therapy on-site at partner hospitals. It serves UK hospitals, hospital groups, and consultant urological surgeons, with 95+ hospital partnerships and 1,000+ procedures supported per year. Named customers include HCA Healthcare, Spire Healthcare, Circle Health Group, Liv Hospital Harley Street, and The New Foscote Hospital.

The company's technology stack centers on third-party equipment—Sonablate HIFU systems (SonaCare Medical), BK 3000 Ultrasound (BK Ultrasound), MIM Fusion Software (MIM Software), and ancillary hardware from Civco, Parity Medical, AngioDynamics, Koelis, and Mermaid Medical—deployed on a mobile basis. The proprietary layer is clinical: subspecialist radiologists, led by Dr Clare Allen (PROMISE Trial lead radiologist, UCL) and Dr Francesco Giganti (co-creator of PI-QUAL/PRECISE scores), analyse six mpMRI sequences (T2-weighted, ADC, diffusion, vascularity patterns) to deliver contoured targeting plans 24-48 hours pre-procedure. Application Specialists then manage fusion software, grid alignment, and theatre logistics in the operating room, while 3D patient reports visualize lesion mapping and biopsy cores.

Commercially, Prostate Care operates a fully managed, B2B enterprise sales motion. Pricing is not publicly disclosed; customers pay for a service that bundles equipment, clinical planning, and on-site specialist support under multi-year contracts with no capital outlay, storage, or maintenance burden. The company employs 1-10 staff, with the public-facing operations team (Claire Lloyd, Emma Frame, Jane Terry) coordinating bookings and logistics. Revenue mechanics are volume-based on procedures supported, with no disclosed funding, ownership changes, or financial statements in the source data.

Name

Prostate Care

Legal name

Prostate Care Limited

Website

https://prostatecare.co.uk

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

Prostate Care Limited is a UK-based managed services provider delivering MR/US fusion biopsy, HIFU treatment, and radiologist-led mpMRI planning to 95+ hospitals, operating a zero-capital-investment model with on-site Application Specialist support.

Ownership category

akta.pro rank

Product category

Prostate Cancer Diagnostic and Treatment Services

NAICS

Diagnostic Imaging Centers (621512)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro industry

PRIMARYHLAKAOAB

Urologic Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Urology

SECONDARYHLAKAOAA

General Urology

Healthcare & Life Sciences/Specialist Medical Practice/Urology

SECONDARYHLAAALAE

Oncology Diagnostics (tumor profiling, MRD, liquid biopsy)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

Keywords

• Prostate diagnostic services
• MR/US fusion biopsy
• HIFU focal therapy
• Radiology biopsy planning
• Managed healthcare equipment

Headquarters

HQ city

Abingdon

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Managed Equipment Services: Full-service managed model providing equipment, Application Specialist support, and technical services to hospitals without capital investment requirements. Equipment is delivered, set up, managed, and removed after procedures.
2. Clinical Planning Services: Radiologist-led mpMRI contouring and targeting plan preparation delivered 24-48 hours before procedure day. Expert clinical planning by subspecialist prostate radiologists including Dr Clare Allen.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Prostate Care Limited delivers fully managed prostate cancer diagnostic and treatment services to UK hospitals, including MR/US fusion biopsy (Freehand TP Pivot Pro and Stepper EX3 Grid), HIFU focal therapy using the Sonablate system, and expert radiologist-led mpMRI biopsy planning. Equipment, clinical planning, and on-site Application Specialists are provided without capital investment from partner hospitals.

Product overview

Prostate Care operates as a managed service provider delivering precision prostate cancer diagnostics and treatment. The core offering combines expert radiologist-led MRI contouring and biopsy planning, MR/US fusion biopsy procedures (with Freehand TP Pivot Pro and Stepper EX3 Grid approaches), and HIFU focal therapy using the Sonablate system. These services are supported by on-site Application Specialists who manage equipment logistics, fusion software, and real-time technical support. The company also provides 3D targeting accuracy reports for enhanced patient communication. All services are delivered without capital investment requirements from partner hospitals.

Differentiator

Problem solved

Functional benefit

Products and services

• MR/US Fusion Biopsy Service On-site MRI/ultrasound fusion biopsy service with Application Specialist support, offering Freehand (TP Pivot Pro) and Stepper (EX3 Grid) approaches for urological surgeons performing precision prostate biopsies at UK hospitals.
• HIFU Treatment Service High Intensity Focused Ultrasound focal therapy using the Sonablate HIFU system for precision ablation of prostate tumour tissue, delivered as a fully managed on-site service at partner hospitals.
• Expert Radiology & Biopsy Planning Radiologist-led multiparametric MRI contouring and targeting plan preparation delivered 24-48 hours before procedure day, with six MRI sequence views (T2-weighted, ADC, diffusion, vascularity) analysed by subspecialist radiologists including Dr Clare Allen.
• 3D Targeting Accuracy Reports Three-dimensional patient communication tool that visualises prostate contours, biopsy locations, and lesion mapping, with reported 85% of patients reporting better understanding and repeat consultations reduced from 85% to 19%.
• Theatre Support Services Application Specialist-managed on-site theatre support including fusion software management, grid alignment, equipment calibration, and sterile technique assistance, enabling surgical teams to focus entirely on patient care during prostate procedures.

Quantifiable outcome

• 90% of patients cancer-free at 1 year following MRI-fusion HIFU treatment (238/265 patients)
• +5 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered core, supportive and strategic.

• SonaCare MedicalcoreTechnology or IntegrationHIFU Surgical Ablation Systems partner providing Sonablate HIFU machine for precision prostate tissue ablation. SonaCare designs and manufactures HIFU systems offering clinical effectiveness and quality-of-life interventions for prostate cancer treatment.
• BK UltrasoundcoreTechnology or IntegrationUltrasound Solutions & Transducers provider offering BK 3000 Ultrasound systems with over 40 years of experience in urology and procedure-driven markets. Provides award-winning systems and unique transducer designs for specialized physician needs.
• MIM SoftwarecoreTechnology or IntegrationMedical Imaging Software Solutions provider offering MIM Fusion Software for MRI-US fusion planning. Provides practical imaging solutions for radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging across PC, Mac, and cloud platforms.
• Civco MedicalsupportiveTechnology or IntegrationCivco Micro Touch Stabiliser provided for MR/US fusion biopsy procedures, ensuring precise probe alignment and stabilization during prostate procedures.
• Parity MedicalsupportiveTechnology or IntegrationParity Medical Cart provided as part of the fusion biopsy equipment setup, supporting the technical requirements of on-site procedures.
• AngioDynamicssupportiveTechnology or IntegrationTechnology partner providing additional equipment solutions for prostate care procedures.
• KoelissupportiveTechnology or IntegrationTechnology partner for prostate imaging and biopsy solutions, integrated into Prostate Care's equipment ecosystem.
• Parker & Son TransportsupportiveImplementation/ SI/ Consulting PartnerEquipment transport and logistics partner handling the complex logistics of ferrying precision equipment including 6DOF stepper systems, ultrasound units, cradles, and calibration tools safely to customer locations and back.
• The Focal Therapy ClinicstrategicStrategic or Co-development PartnerStrategic partner providing clinical audit data for HIFU outcomes (265 consecutive patients 2016-2022). Data published in BJUI Compass demonstrating 90% cancer-free rate, 97% continence, and 97% erectile function preservation at 1 year.
• Mermaid MedicalsupportiveTechnology or IntegrationAdditional technology partner providing medical equipment solutions for prostate care procedures.

Scale indicators8 records

Expansion highlights4 records

Broad incumbents

• Circle Health Group: UK private hospital operator and named Prostate Care enterprise customer for fusion biopsy and HIFU. Comparable as both a customer base and a potential in-houser of advanced prostate diagnostics given its national footprint and capital resources.
• Spire Healthcare: UK-listed private hospital group operating 30+ hospitals and a named Prostate Care enterprise customer. Comparable as a major private hospital customer that, like HCA, could in-source fusion biopsy and HIFU capability if volume justifies capital outlay.
• HCA Healthcare UK: One of the largest private hospital operators in the UK and a named Prostate Care customer for fusion biopsy and HIFU services. Comparable as both a customer and a potential in-houser of prostate diagnostics given the scale and capital base of the group.
• EDAP TMS: Global leader in therapeutic ultrasound including the Focal One HIFU device for prostate cancer. Competes indirectly with Prostate Care's Sonablate-based HIFU service at the device/technology layer that Prostate Care's managed service wraps around.

Direct peers

• Koelis: French-headquartered developer of MRI/TRUS fusion biopsy systems (e.g., Trinity, Prime) used in targeted prostate biopsies. Competes head-to-head with Prostate Care's MR/US fusion biopsy service at the device-and-workflow layer for the same hospital urology customers.
• The Focal Therapy Clinic: UK-based clinic providing focal HIFU and prostate cancer focal therapy services. Listed as a Strategic co-development partner that supplied Prostate Care's 265-patient clinical audit; operates in the same patient pathway, geography, and modality (HIFU focal therapy) as Prostate Care.

Others

• AngioDynamics: Medical device company whose Nanoknife irreversible electroporation system is among the equipment Prostate Care deploys on-site. Adjacent/ecosystem enabler operating in the same prostate treatment device category rather than as a direct service competitor.
• MIM Software: Provider of MIM Fusion Software used for MRI-US fusion planning at the core of Prostate Care's biopsy planning service. Technology partner whose software platform is integral to Prostate Care's mpMRI contouring and targeting workflow.
• SonaCare Medical: Manufacturer of the Sonablate HIFU system that Prostate Care uses for prostate ablation. Strategic technology partner and adjacent ecosystem enabler whose devices sit underneath Prostate Care's managed service offering.

Emerging players

• Profound Medical: Developer of the TULSA-PRO MRI-guided transurethral ultrasound ablation system for prostate tissue. Competes with Prostate Care's HIFU offering via an alternative focal therapy modality with its own MRI-based real-time control, addressing the same urological oncology procedures.

Market position

Strengths4 records

Weaknesses4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ada-medical-ltd
• Facebookfacebook.com/nuadamedical

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prostate Care